Nanocatalytic treatment of oral squamous cell carcinoma Cal 27 cells in vitro based on single-atom iron nanocatalysts

doi:10.19439/j.sjos.2024.02.002

Abstract

Abstract: PURPOSE: To prepare single-atom iron nanocatalysts(SAF NCs) and explore its efficacy on oral squamous cell carcinoma Cal 27 cells in vitro, and provide a new strategy for the treatment of oral squamous cell carcinoma. METHODS: SAF NCs were prepared with combination of isolation and pyrolysis, the microscopic characterization was observed by transmission electron microscopy, the morphology and chemical composition were analysed by X-ray diffractograms and elemental distribution energy spectroscopy. The catalytic properties were detected by TMB assay and electron spin resonance test, and finally the changes in the activity of Cal27 cells were observed by CCK-8, flow cytometry and confocal microscopy for in vitro treatment of oral squamous carcinoma, to investigate the therapeutic effect against Cal27 cells. Statistical analysis was performed with GraphPad Prism 9 software package. RESULTS: SAF NCs were successfully synthesized and characterized, which showed excellent catalytic properties at the solution level and good biocompatibility in in vitro cellular level. The viability of Cal27 cell was reduce to 32.08% after in vitro catalytic treatment under conditions mimicking the characteristics of the tumor microenvironment. CONCLUSIONS: Preliminary experiments demonstrated that SAF NCs with good biological properties could effectively inhibit the proliferation of Cal 27 cells in vitro, providing a new strategy for the treatment of oral squamous carcinoma.

Key words: Oral squamous cell carcinoma, Nanocatalysis, Single atom nanocatalysts, Cal 27

CLC Number:

R739.8

XIE Yu-ting, XIONG Ping. Nanocatalytic treatment of oral squamous cell carcinoma Cal 27 cells in vitro based on single-atom iron nanocatalysts[J]. Shanghai Journal of Stomatology, 2024, 33(2): 117-122.

References

[1] Vadovics M, Ho J, Igaz N, et al.Candida albicans enhances the progression of oral squamous cell carcinoma in vitro and in vivo[J]. mbio, 2022, 13(1) : e0314421.
[2] Joseph JP, Harishankar MK, Pillai AA, et al.Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC[J]. Oral Oncol, 2018, 80: 23-32.
[3] Huang SH, O'Sullivan B. Overview of the 8th Edition TNM classification for head and neck cancer[J]. Curr Treat Options Oncol, 2017, 18(7): 40-52.
[4] Chai AWY, Lim KP, Cheong SC.Translational genomics and recent advances in oral squamous cell carcinoma[J]. Semin Cancer Biol, 2020, 61: 71-83.
[5] 中华口腔医学会口腔病理学专业委员会. 唾液腺肿瘤病理诊断规范[J]. 中华病理学杂志, 2021, 50(3) : 185-189.
[6] Zanoni DK, Montero PH, Migliacci JC, et al.Survival outcomes after treatment of cancer of the oral cavity (1985-2015)[J]. Oral Oncol, 2019, 90(1): 115-121.
[7] Zittel S, Moratin J, Horn D, et al.Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study[J]. Clin Oral Investig, 2022, 26(2): 2055-2064.
[8] Jing X, Hu H, Sun Y, et al.The intracellular and extracellular microenvironment of tumor site: the trigger of stimuli-responsive drug delivery systems[J]. Small Methods, 2022, 6(3): e2101437.
[9] Boedtkjer E, Pedersen SF.The acidic tumor microenvironment as a driver of cancer[J]. Annu Rev Physiol, 2020, 82: 103-126.
[10] Wang X, Zhong X, Liu Z, et al.Recent progress of chemodynamic therapy-induced combination cancer therapy[J]. Nano Today, 2020, 35: 100946.
[11] Zhang L, Li CX, Wan SS, et al.Nanocatalyst-mediated chemodynamic tumor therapy[J]. Adv Healthc Mater, 2022, 11(2): e2101971.
[12] Yang B, Chen Y, Shi J.Nanocatalytic medicine[J]. Adv Mater, 2019, 31(39): e1901778.
[13] Zhao M, Zhang N, Yang R, et al.Which is better for nanomedicines: nanocatalysts or single-atom catalysts?[J]. Adv Healthc Mater, 2021, 10(8) : e2001897.
[14] Jiang S, Zhang C, Zou T.Single-atom catalysts for biotherapy applications: a systematic review[J]. Nanomaterials(Basel), 2020, 10(12) : 2518.
[15] Yan R, Sun S, Yang J, et al.Nanozyme-based bandage with single-atom catalysis for brain trauma[J]. ACS Nano, 2019, 13(10): 11552-11560.
[16] Xiang H, Feng W, Chen Y.Single-atom catalysts in catalytic biomedicine[J]. Adv Mater, 2020, 32(8) : e1905994.
[17] Lu X, Gao S, Lin H, et al.Bioinspired copper single-atom catalysts for tumor parallel catalytic therapy[J]. Adv Mater, 2020, 32(36): e2002246.
[18] Lu X, Gao S, Lin H, et al.Single-atom catalysts for nanocatalytic tumor therapy[J]. Small, 2021, 17(16) : e2004467.
[19] Huo M, Wang L, Wang Y, et al.Nanocatalytic tumor therapy by single-atom catalysts[J]. ACS Nano, 2019, 13(2): 2643-2653.